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miceMosaic analysis with double markers (MADM) technology enables the generation of genetic
mosaic tissue in mice. MADM enables concomitant fluorescent cell labeling and introduction of a
mutation of a gene of interest with single-cell resolution. This protocol highlights major steps for
the generation of genetic mosaic tissue and the isolation and processing of respective tissues for
downstream histological analysis.Amberg & Hippenmeyer,
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Mosaic analysis with double markers (MADM) technology enables the generation
of genetic mosaic tissue in mice. MADM enables concomitant fluorescent cell la-
beling and introduction of a mutation of a gene of interest with single-cell reso-
lution. This protocol highlights major steps for the generation of genetic mosaic
tissue and the isolation and processing of respective tissues for downstream his-
tological analysis.
For complete details on the use and execution of this protocol, please refer to
Contreras et al. (2021).
BEFORE YOU BEGIN
Background
This protocol describes the generation of genetic mosaic mice using mosaic analysis with double
markers (MADM) (Zong et al., 2005; Contreras et al., 2021). A genetic mosaic individual consists
of cells of distinct genotypes, for example harboring homozygous mutant cells next to wild-type
cells. This phenomenon occurs naturally and is widespread across multicellular organisms. The ad-
vantages of using genetic mosaic animals for experimental studies are manifold: The controlled
induction of genetic mosaicism in experimental animals allows to alter gene function at high spatio-
temporal resolution and has led to many fundamental discoveries of gene function and cellular
mechanisms in diverse biological contexts. Genetic mosaicism can be induced sparsely, so that in-
dividual mutant cells will be surrounded by unperturbed cells. Thus, mosaicism enables the study of
cell-autonomous gene function at single cell resolution. Individual mutant cells can be studied in
many ways, for example in lineage tracing, cell competition assays, morphological analysis and dis-
easemodelling (Hippenmeyer et al., 2010; Gao et al., 2014; Joo et al., 2014; Beattie et al., 2017; Tian
et al., 2020; Contreras et al., 2021).
In this protocol, we present an experimental pipeline for the generation of MADM-labeled mosaic
tissues and highlight a variety of downstream analysis applications. Our protocol is based on the
use of distinct Cre drivers in combination with MADM cassettes targeted to all 19 mouse autosomes
(Contreras et al., 2021).
Mosaic analysis with double markers (MADM) is a genetic technology that allows concomitant fluo-
rescent labeling and introduction of a homozygous mutation of choice with unprecedented single
cell resolution in a defined genetic lineage (Zong et al., 2005; Contreras et al., 2021). MADM is based
on the use of split marker genes that consist of two reciprocal cassettes of partial coding sequences
for green fluorescent protein (GFP) and tandem dimer Tomato (TdT), interspersed by loxP sites
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(Figure 1A). The two reciprocal MADM cassettes need to bemaintained in two different mouse lines,
the GT (N-GFP/C-TdT) line and the TG (N-TdT/C-GFP) line (Zong et al., 2005; Hippenmeyer et al.,
2010).
Figure 1. The MADM principle
(A) For MADM, two reciprocally chimeric marker genes are targeted to identical loci on homologous chromosomes.
The chimeric marker genes (GT and TG alleles) consist of partial coding sequences for green (eGFP[G]) and red (tdT
[T]) fluorescent proteins separated by an intron containing the loxP site. Following Cre recombinase-mediated
interchromosomal recombination during mitosis, functional green and red fluorescent proteins are reconstituted.
(B) G2-X segregation of the recombinant chromosomes results in two daughter cells each expressing one of the two
fluorescent proteins (recombination in G2 of the cell cycle followed by X segregation). Introduction of a mutation
distal to one MADM cassette (here the TG cassette) allows the generation of genetic mosaics with single cell
resolution, with wild-type daughter cells labeled in red and homozygous mutant sibling cells labelled in green in an
unlabeled heterozygous environment.
(C) G2-Z segregation results in two daughter cells with no genotype alteration. One cell shows double labeling (=
yellow), while the other daughter cell is unlabeled.
(D) G1 and G0 events also result in yellow cell labeling without change in genotype.
Reproduced and adapted with permission from (Contreras et al., 2021).
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In order to generate genetic mosaic tissue, a modified gene of interest needs to be meiotically re-
combined with one of the MADM chromosomes (here shown as coupled to the TG line, resulting in
an animal being heterozygous for the gene modification of interest). Additionally, one of the lines
needs to carry a Cre driver of interest for the generation of experimental animals. Cells with
MADM-induced mosaicism are generated by Cre/loxP-dependent mitotic interchromosomal
recombination during the G2 phase in dividing progenitor/stem cells followed by X-segregation
(that is the transmission of the two recombinant chromosomes to distinct daughter cells, resulting
in individual green (GFP+) mutant and red (tdT+) wild-type cells) (Figures 1A and 1B). Recombination
in the G2 phase of the cell cycle with segregation of both recombinant chromosomes to the same
daughter cell (Z-segregation) does not alter the genotype and results in one yellow GFP+/tdT+ het-
erozygous cell which serves as control. At the same time, Z-Segregation results in transmission of the
non-recombined chromosomes to the other sibling daughter cell and thus gives rise to an unlabeled
cell (unchanged genotype, heterozygous) (Figure 1C). G1 and/or postmitotic G0 events also result in
yellow cells (Figure 1D).
Importantly, the existence of sparse green mutant, red wild-type and yellow heterozygous cells in an
otherwise unlabeled heterozygous environment not only allows to study gene function, but also to
perform gene dosage analysis at the individual cell level within the same tissue, in a cell-type-specific
manner.
Here, we demonstrate the coupling of the mutant allele of interest with the TG line, which upon suc-
cessful Cre-mediated recombination will result in genetic mosaic tissue consisting of sparse genet-
ically modified cells labeled in green, while corresponding wild-type cells will be labeled in red and
all other cells (yellow and unlabeled) will be heterozygous (Figure 1).
For more details on the MADM technology, please refer to Zong et al. (2005), Beattie et al. (2020),
Laukoter et al. (2020a), and Contreras et al. (2021).
For the successful generation of experimental MADM mice, a number of considerations have to be
taken into account before starting with breeding (also see troubleshooting problem 1):
1. Institutional and governmental permission and oversight information for the animal study should
be obtained. In this study, experimental procedures were discussed and approved by the institu-
tional ethics and animal welfare committees at IST Austria in accordance with good scientific
practice guidelines and national legislation (license number: BMWF-66.018/0007-II/3b/2012
and BMWFW-66.018/0006-WF/V/3b/2017).
2. For MADM to work, the presence of a Cre recombinase, active in stem or progenitor cells of
your tissue of interest, is required. In other words, any Cre-driver can be used, provided Cre
is expressed in dividing stem and progenitor cells, to target cell types and lineages of inter-
est.
3. MADM can be employed for both population and clonal analysis. Depending on the aim of
your experiments, you are required to choose a Cre driver enabling either population
analysis (constitutively active Cre) or clonal analysis (e.g., tamoxifen (TM)-inducible CreER
driver).
Population analysis allows the analysis of a high number of single, sparsely labeled cells in one organ
to obtain a highly quantitative read-out. However, constitutively active Cre will result in MADM
events at any time point during the entire time window of Cre activity (e.g., Emx1-Cre activity starts
at E9.5 and is detectable up to early postnatal age). Given this relatively long activity window, the
detection of labeled cells does not provide information about the spatiotemporal origin of these
cells or the stem cell division mode.
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In order to get to spatiotemporally controlled induction of MADM events clonal analysis, employ-
ing a TM-inducible CreER driver, can be used. Injection of one single low dose of TM allows the
induction of G2-X MADM events only at the injection time point, thus generating high spatiotem-
poral resolution and conserving information about stem cell division modes. For more detailed in-
formation about the usage of the MADM system for clonal analysis, please refer to (Beattie et al.,
2020).
4. Make use of meiotic recombination in the germline to genetically link a mutant allele of your gene
of interest to the corresponding MADM chromosome (Hippenmeyer et al., 2010; Laukoter et al.,
2020b) (Figure 1). The probability for meiotic recombination that results in the linkage of the
mutant allele with the MADM cassette can be estimated: By determining the genetic distance
(centi-Morgan [cM]) between the gene locus of interest and the MADM cassette on a particular
chromosome by using for example Mouse Genome Informatics (MGI) database (www.
informatics.jax.org) (Figure 2A).
5. Choose MADM chromosomes according to the chromosomal location of your gene of interest.
For example, if your gene of interest is located on chromosome 7, you need to recombine it
with a MADM cassette localized on chr.7 (MADM-7). If your gene of interest is located on chro-
mosome 11 (as shown in our example in Figure 2), you need to recombine it with a MADM
cassette localized on chr.11 (MADM-11). We have reported distinct MADM recombination fre-
quencies for different MADM chromosomes. Consider the frequency when evaluating your
results, particularly when frequency is low and results appear highly variable (also see trouble-
shooting problem 3). In the original manuscript corresponding to this protocol, we provide a
detailed description of MADMGT and TG cassettes for all 19 mouse autosomes including primer
sequences for genotyping (Contreras et al., 2021).
We provide an example in Figure 2 using the candidate gene Ndel1, which is located on chromo-
some 11, and thus needs to be recombined to MADM chromosome 11. MADM-11 cassettes are
3 cM distal to the centromere and Ndel1 is located 42 cM distal to the centromere, or 39 cM
away from the MADM cassettes. Thus, there is 39% probability that meiotic recombination will
occur in the recombinant generating mating. However, since only half of the progeny will be of
the desired genotype (TG,mutant), while the other half will be wild-type (+,+), animals with the
appropriate genotype will be generated at a rate of 20% (39% 3 1/2) (Figure 2A).
6. The larger the genetic distance between theMADM cassette and the genomic locus of your gene
of interest, the higher the recombination probability. The scale of the mating for generating re-
combinants using meiotic recombination needs to be adjusted according to the recombination
probability. In other words, the probability of meiotic recombination determines the amount of
matings you require to set up in order to successfully obtain mice where MADM cassettes and
genes of interest are genetically linked. The higher the recombination probability, the less
breeding cages will be needed to obtain recombinants.
Note: All information provided in this section is specific to the example geneNdel1 in order to
provide numerical calculation support to the reader. The numbers and probabilities for your
specific experiments require adjustments based on your genes of interest and the required
MADM chromosomes.
7. The MADM targeting constructs were introduced into C57BL/6N embryonic stem cells and in-
jected into blastocysts isolated from BALB/cRj females. The offspring were bred with C57BL/
6NRj females. Further backcrossing of offspring positive for MADM cassettes was performed
with CD1 mice to obtain MADM stock lines of mixed CD1-C57BL/6J genetic background.
Consider variances in litter size or phenotype based on mouse background, particularly when
you are usually employing pure inbred mice for your experiments.
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Figure 2. Calculation of meiotic recombination frequency and breeding schemes for MADM mice
(A) Calculation of meiotic recombination frequency to genetically link the gene of interest (here Ndel1) to the
corresponding MADM chromosome (here MADM-11).
(B) Breeding strategy 1 for maximal output efficiency in the generation of experimental MADM mice. (i) In the first
breeding step, the mouse line carrying the mutation of interest is bred to the TG cassette of the corresponding MADM
chromosome. (ii) In a second step, MADM cassettes are homozygosed by crossing the trans-heterozygote offspring
from (i) with animals homozygous for the TG cassette. Thereby, the mutation of gene-X is genetically linked (through
meiotic recombination) to the MADM TG cassette on the corresponding MADM chromosome. (iii) In parallel to steps
(i) and (ii), the first breeding step for the Cre driver is performed by crossing the Cre line of choice with the GT line. (iv)
In a second step, MADM cassettes are homozygosed by performing an intercross of the double heterozygous
offspring from (iii). (v) Mating setup resulting in experimental MADMmice with mutant cells labelled in green and wild-
type cells labelled in red. (vi) Summary of the required breeding cages to obtain 5 experimental MADM mice. The
breeding strategy allows to obtain 50% of genetic mosaic MADM animals from one experimental mating.
(C) Breeding strategy 2 for maximal temporal efficiency in the generation of experimental MADM mice. (i) In the first
breeding step, the mutation of gene-X is genetically linked to the MADM TG cassette on the corresponding MADM
chromosome. (ii) In parallel, the Cre driver is bred to the GT line. All mice of the F1 generation will be heterozygous for
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MADM cassettes, gene-X and Cre, respectively. (iii) The breeding step rendering the MADM cassettes homozygous is
skipped and F1 mice are used directly to set up the mating resulting in experimental MADM animals with mutant cells
labelled in green and wild-type cells labelled in red. (iv) Summary of the required breeding cages to obtain 5
experimental MADMmice. The strategy allows to obtain mosaic animals at a frequency of5% from10 experimental
matings.
REAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, peptides, and recombinant proteins
PFA Sigma-Aldrich Cat# 441244
103 PBS Thermo Fisher Scientific Cat# 70011
Triton X 100 Sigma-Aldrich Cat# T878
Tween 20 Sigma-Aldrich Cat# P9416
0.2M Tris HCL pH 8.5 CARL ROTH Cat# 9090
NaH2PO4$2H2O Sigma-Aldrich Cat# 567549
Na2HPO4 Sigma-Aldrich Cat# S3264
Glycerol Sigma-Aldrich Cat# G5516
Citric Acid CARL ROTH Cat# X863.1
NaOH CARL ROTH Cat# T198.1
Heat-inactivated Horse Serum (HS) Thermo Fisher Scientific Cat#26050088
Avertin (2,2,2 triboromoethanol) Sigma-Aldrich Cat# T48402
t-amylalcohol (2-methyl-2-butanol) Sigma-Aldrich Cat# 240486
Ethanol Honeywell Cat# 24194
Sucrose Sigma-Aldrich Cat# S8501
O.C.T. Tissue Tek Sakura Cat# 4583
Mowiol 4-88 CARL ROTH Cat# 0713
DABCO CARL ROTH Cat# 0718
DAPI Molecular Probes Cat# D1306
Antibodies
Chicken anti-GFP antibody, 1:400 Aves RRID:AB_10000240
Goat anti-tdT antibody, 1:400 SICGEN ANTIBODIES RRID:AB_2333092




Donkey anti-goat Alexa568 secondary
antibody, 1:1000
Molecular Probes RRID:AB_2534104




Mouse: MADM-7-GT The Jackson Laboratory RRID:IMSR_JAX:021457
Mouse: MADM-7-TG The Jackson Laboratory RRID:IMSR_JAX:021458
Mouse: MADM-11-GT The Jackson Laboratory RRID:IMSR_JAX:013749
Mouse: MADM-11-TG The Jackson Laboratory RRID:IMSR_JAX:013751
Mouse: MADM-18-GT (Contreras et al., 2021) N/A
Mouse: MADM-18-TG (Contreras et al., 2021) N/A
Mouse: Emx1-Cre The Jackson Laboratory RRID:IMSR_JAX:005628
Mouse: Emx1-CreER The Jackson Laboratory RRID:IMSR_JAX:027784
Mouse: Nestin-Cre (Petersen et al., 2002) N/A
Mouse: Nestin-CreER (Imayoshi et al., 2006) N/A
Mouse: Hprt-Cre The Jackson Laboratory RRID:IMSR_JAX:004302
Mouse: Apc-flox The Jackson Laboratory RRID:IMSR_JAX:009045
Mouse: TrkC (Tessarollo et al., 1997) N/A
Mouse: Ndel1 The Jackson Laboratory RRID:IMSR_JAX:026958
Mouse: Lgl1-flox (Klezovitch et al., 2004) N/A
(Continued on next page)
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MATERIALS AND EQUIPMENT
Essential buffers and anesthesia for tissue harvesting (prepare 1 day prior to the experiment)
Timing: 60 min
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Software and algorithms




GraphPad Prism GraphPad https://www.graphpad.com/scientific-
software/prism/
Other
Histosette (embedding cassette for
tissue fixation)
Sakura Cat# 4170-01
Embedding molds for peripheral organs Sakura Cat# 4557
Embedding molds for coronal brain sections Polysciences, Inc.. Cat# 18986-1
Embedding molds for sagittal brain sections Polysciences, Inc. Cat# 18646A-1
6 well plates TPP Cat# 92406
24 well plates TPP Cat# 92424
Flask Filters 500mL TPP Cat# 99505
Microfuge Tubes 1.5 mL Thermo Fisher Scientific Cat# AM12450
50 mL Centrifuge Tubes Sarstedt, Inc. Cat# 62.547.254
15 mL Centrifuge Tubes Sarstedt, Inc. Cat# 62.554.502
Syringe 60mL Kendall Cat# 560125
Syringe 10 mL Omnifix B.Braun Cat# 4617100V
Needle 20G Sterican B.Braun Cat# 4657705
0.2micron filter Nalgene Cat# 194-2520
Peristaltic Pump Watson-Marlow Cat# 323 S/D
Hydrophobic Pen DAKO Cat# S2002
Petri dish Thermo Fisher Scientific Cat# NC9565080
Slide Moisture Chamber black Newcomer Supply Cat# 68432A
Superfrost Glass Slides Thermo Fisher Scientific Cat# J1800AMNZ
Cover Slips 24 3 50 mm VWR 631–0147
Dissection Tools Freudenberg FST Various, depending on the specific
needs of the experiment
Fine Brush Size 1 Ted Pella, Inc. Cat# 11859
LSM 800 Confocal ZEISS N/A
Cryostat Cryostar NX70 Thermo Fisher Scientific N/A
1M PB buffer (pH 7.4)
Reagent Final concentration Amount
2M NaH2PO4
. 2H2O (monobasic sodium phosphate) 1M 47.5 mL
2M Na2HPO4 (dibasic sodium phosphate) 1M 202.5 mL
ddH2O n/a 250 mL
Total 1M 500 mL
Keep at 22C–25C.
2N NaOH
Reagent Final concentration Amount
NaOH 2N 40 g
ddH2O n/a 500 mL
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Prepare perfusion equipment (on the day of experiment)
Timing: 15 min
 Clean all dissection tools (2 curved forceps, large and small scissors) with 70% ethanol.
 Prepare a perfusion pad and whipping tissues.
 Prepare a peristaltic pump or two 10 mL syringes and needles for perfusion.
 Prepare 6-well plates filled with 4% PFA to collect brain tissues.
 Prepare histosettes and a beaker filled with 4% PFA to collect peripheral organs.
4% PFA (in 0.1M PB buffer)—always prepare fresh PFA
Reagent Final concentration Amount
Paraformaldehyde (PFA) 4% 40 g
2N NaOH 0.01N 4 mL
1M PB buffer 0.1M 100 mL
ddH2O n/a 850 mL
Total 4% 1,000 mL
Details for PFA preparation: (1) Dissolve 40 g of PFA in 750 mL distilled water. (2) Add 4 mL 2N NaOH. (3) Place on a stirring
heating plate at 55C until all PFA has dissolved. (4) Add 100 mL 1M PB buffer. (5) Fill up the volume to 1000 mL with distilled
water. (6) Filter through a flask filter to avoid residual undissolved PFA particles. (7) Store at 4C for up to 1–2 days.
Anesthesia stock solution (100%)
Reagent Final concentration Amount
Avertin 100% 7 g
t-amylalcohol n/a 7 mL
Total 100% 7 mL
Details for anesthesia preparation: (1) Vortex until the solution appears homogeneous. (2) Wrap in tin foil to protect from light
and store at 22C–25C for up to 6 months.
Anesthesia working solution (2.5%)
Reagent Final concentration Amount
100% anesthesia stock solution 2N 0.875 mL
13 PBS 13 34.125 mL
Total 2.5% 35 mL
Details for anesthesia preparation: (1) Vortex until the solution appears homogeneous. (2) Filter the solution into a fresh tube
using a 60 mL syringe and a 0.2micron filter. (3) Store at 4C for up to one month.
13 PBS:
Reagent Final concentration Amount
103 PBS 13 100 mL
ddH2O n/a 900 mL
Total 13 1,000 mL
Keep at 22C–25C.
Sucrose
Reagent Final concentration Amount
Sucrose 30% 300 g
13 PBS 13 Add up to 1,000 mL
Total 30% 1,000 mL
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Prepare essential buffers and reagents for histological stainings (on the day of the
experiment)
Cryoprotectant
Reagent Final concentration Amount
Glycerol 60% 300 mL
1M PB buffer 0.1M 50 mL
ddH2O n/a 150 mL
Total 60% 500 mL
Store at 4C.
PBS with 0.5% Tween (PBS-T)
Reagent Final concentration Amount
Tween20 0.5% 5 mL
13 PBS 13 995 mL
Total 0.5% 1000 mL
Add 5 mL Tween20 to 1,000 mL 13 PBS and mix well. Store at 22C–25C.
Citrate buffer pH 6.0
Reagent Final concentration Amount
Citric acid anhydrous (192M) 1M 1.92 g
Tween20 0.05% 0.5 mL
ddH2O n/a 1,000 mL
Total 1M 1,000 mL
Details for citrate buffer preparation: (1) Dissolve 1.92 g citric acid anhydrous (192M) in 1000 mL distilled water. (2) Adjust to
pH 6.0 using NaOH. (3) Add 0.5 mL of Tween20. (4) Store at 4C.
Triton-X-100 working solution
Reagent Final concentration Amount
Triton-X-100 20% 2 mL
ddH2O n/a 8 mL
Total 20% 10 mL
Store it in a 15 mL Falcon tube at 22C–25C.
Blocking buffer
Reagent Final concentration Amount
Horse Serum 10% 1 mL
Triton-X-100 working solution 0.5% 0.25 mL
13 PBS 13 8.75 mL
Total n/a 10 mL
Store it in a 15 mL Falcon tube at 4C.
Staining buffer
Reagent Final concentration Amount
Horse Serum 5% 0.5 mL
Triton-X-100 working solution 0.5% 0.25 mL
13 PBS 13 9.25 mL
Total n/a 10 mL
Store it in a 15 mL Falcon tube at 4C.
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Note: You can prepare 1,000 ml of Blocking and Staining Buffer and aliquot in 50 mL or 15 mL
tubes, which can be stored at20C until further usage. Once thawed, keep at 4C and use up
within 1 week.
STEP-BY-STEP METHOD DETAILS
Breeding of experimental MADM mice for the generation of genetic mosaic tissue
Timing: 4–7 months
In order to generate genetic mosaic mice, you can either chose a breeding strategy maximizing the
efficiency of experimental MADM animal output (here called ‘‘strategy 1’’) or a breeding strategy
maximizing the speed of obtaining experimental MADM animals (here called ‘‘strategy 2’’) (Figures
2B and 2C). We provide an estimated amount of breedingmice required to obtain a realistic number
of experimental MADM animals (Figures 2B and 2C). We provide step-by-step breeding guidance in
the following section of this protocol (also see troubleshooting problem 1):
1. For both breeding strategies, perform Breeding step 1 for gene-X of interest: In order to link the
mutation of gene-X to the MADM TG cassette, cross MADMTG/TG animals with a mouse line
mutant for gene-X (Figures 2B(i) and 2C(i)). The resulting F1 generation will be trans-heterozy-
gous for the MADM TG cassette and the mutation of interest (genotype will be MADMTG/+;
gene-X+/-).
2. For both breeding strategies, perform Breeding step 1 for the Cre driver (Figures 2B(iii) and
2C(ii)): cross MADMGT/GT animals with a Cre driver of choice. The resulting F1 generation will
DAPI stock solution
Reagent Final concentration Amount
1 vial DAPI 5 mg/mL 10 mg
ddH2O n/a 2 mL
Total 5 mg/mL 2 mL
Aliquot in 1.5 mL tubes and store at 20C.
DAPI working solution
Reagent Final concentration Amount
DAPI stock solution 300nM 1 mL
13 PBS 13 20 mL
Total 300nM 20 mL
Store at 2C–6C up to one week, protected from light.
Embedding medium Mowiol-DABCO
Reagent Final concentration Amount
Glycerol n/a 6 g
Mowiol n/a 4 g
ddH2O n/a 6 mL
0.2M Tris-HCl (pH 8.5) 0.1 12 mL
DABCO n/a 25 mg
Total n/a 25 mL
Details for Mowiol-DABCO preparation: (1) Use a balance to weight 6.0 g Glycerol and 2.4 g Mowiol. Given the high viscosity
of Glycerol, it is more accurate to measure its weight than its volume. (2) Mix both reagents and dissolve for 1 h on a stirring
plate. (3) Add 6 mL distilled water and mix for another hour. (4) Add 12 mL 0.2M Tris-HCl (pH 8.5) and incubate for 2 h at 50C
on a stirring heating plate. (5) It is likely that not all Mowiol is going to dissolve. Thus, you can add an additional centrifugation
step to remove undissolved Mowiol from the preparation by centrifuging for 15 min at 5,000 g and keeping the supernatant.
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be double heterozygous for the MADMGT cassette and the Cre driver specific for the cell type of
interest (MADMGT/+; Cre+/-). Perform this step in parallel to the above step.
Allow F1 generation mice to grow up to 8 weeks of age. For breeding strategy 2, proceed to step 6.
For breeding strategy 1, continue with steps 3, 4 and 5.
3. For strategy 1, perform Breeding step 2 for the mutant by crossing MADMTG/+;gene-X+/- mice
with MADMTG/TG animals in order to generate F2 offspring homozygous for the MADM TG
cassette and meiotically linked gene-X (MADMTG/TG,gene-X) (Figure 2B(ii)).
4. For strategy 1, perform Breeding step 2 for the Cre driver by intercrossing MADMGT/+; Cre+/-
mice with MADMGT/+; Cre+/- animals in order to generate F2 offspring homozygous for the
MADM GT cassette and the Cre driver. The resulting genotype will be MADMGT/GT; Cre+/+ (Fig-
ure 2B(iv)). Perform this step parallel to step 3.
Allow F2 generation mice to grow up to 8 weeks of age.
5. For the generation of experimental MADM animals according to strategy 1, cross
MADMTG/TG,gene-X mice with MADMGT/GT; Cre+/+ animals in order to generate experimental
offspring with genetic mosaic tissue with green mutant, red wild-type and yellow heterozygous
cells (Figure 2B(v)).
The genotype of the experimental MADM animals is MADMGT/TG,gene-X; Cre+/- (Figure 2B(v)).
The probability to obtain experimental MADM animals from this breeding is 50%. The probability
for control-MADM animals is also 50%, i.e., animals with MADM-labelling but without mutation.
With an estimated litter size of 10 pups per litter, this means that you require 1 breeding cage to
obtain a total of 5 experimental MADM mice (Figure 2B(vi)).
a. Check for the vaginal plug to monitor successful mating and to expedite the experimental
planning.
b. Male and female offspring can be used as experimental animals.
c. Perform experiment at developmental stage(s) of choice.
6. For the generation of experimental MADM animals according to strategy 2, cross trans-heterozy-
gous MADMTG/+;gene-X+/-mice directly with double heterozygousMADMGT/+; Cre+/- animals in
order to generate experimental MADM offspring with genetic mosaic tissue with green mutant,
red wild-type and yellow heterozygous cells (Figure 2C(iii)).
The genotype of the experimental MADM animals is MADMGT/TG,gene-X; Cre+/- (Figure 2C(iii)).
The probability to obtain experimental MADM animals from this breeding is 5%. With an esti-
mated litter size of 10 pups per litter, you require10 breeding cages and 100 pups to obtain a
total of 5 experimental MADM mice (Figure 2C(iv)).
a. Check for the vaginal plug to monitor successful mating and to expedite the experimental
planning.
b. Male and female offspring can be used as experimental animals.
c. Perform experiment at developmental stage(s) of choice.
Note: In the following examples described in this protocol, all tissue was analyzed at specific
postnatal stages. However, experimental animals can also be used at embryonic stages, P0,
and any postnatal age depending on your experimental needs.
In order to provide a broad overview of applications suitable for histological analysis using
MADM in this protocol, we made use of a number of different Cre drivers: (1) constitutively
active Emx1-Cre and TM-inducible Emx1-CreER that primarily targets radial glia progenitors
in the dorsal forebrain, which give rise to excitatory projection neurons and glial cells in the
cerebral cortex (Gorski et al., 2002; Kessaris et al., 2006). (2) We include an example using
constitutively active Nestin-Cre and inducible Nestin-CreER (Petersen et al., 2002; Imayoshi
et al., 2006), which is a marker of stem cells across the nervous system and therefore results
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in MADM labeling in all neural cell types including Purkinje cells; (3) and make use of consti-
tutively activeHprt-Cre (Tang et al., 2002) which shows ubiquitous spatiotemporal expression.
The Hprt-Cre driver was utilized to investigate peripheral organs, in particular the intestine.
MADM can also be applied for experiments involving flow cytometry. For details and a step-
by-step protocol on the experimental workflow specific for flow cytometry experiments, we
refer to (Laukoter et al., 2020a).
Specific considerations when breeding experimental MADM animals are provided in the next
two sections of the protocol:
Generation of experimental MADM mice for postnatal histological analysis in brain
Timing: 3 weeks–12 months
7. For population analysis, cross MADMGT/GT; Emx1Cre/Cre or MADMGT/GT; Nestin-Cre+/+ females
withMADMTG/TG;gene-Xmales in order to generate offspring with genetic mosaic brain tissue (Fig-
ure 2B, bottom panel) (also see troubleshooting problem 4).
For clonal analysis, crossMADMGT/GT; Emx1CreER/CreER orMADMGT/GT; Nestin-CreER+/+ females
with MADMTG/TG;gene-X males in order to generate offspring with genetic mosaic brain tissue
following TM injection at a time point of choice (Figure 2B, bottom panel) (also see trouble-
shooting problem 5).
For simplicity, the above mentioned distinct Cre/ER drivers will be abbreviated as ‘‘Cre’’
throughout step 7.
a. Check for the vaginal plug to monitor successful mating and to facilitate the experimental
planning.
b. Males and females of the resulting F1 generation can be used as experimental animals
(genotype will be MADMGT/TG,gene-X; Cre+/-).
Note: Upon crossing MADMGT/GT; Cre+/+ females with MADMTG/TG,gene-X males to generate
MADMGT/TG,gene-X; Cre+/- mosaic animals, green cells harboring a homozygous mutation in
gene-X will show uniparental paternal chromosome disomy (patUPD, PP), while red wild-
type cells will show uniparental maternal chromosome disomy (matUPD, MM) (Figure 3A).
We refer to this breeding scheme as ‘default breeding scheme.’
Note: In order to reverse the fluorescent colors to control for a potential bias of the fluorescent
reporter (color swap), couple the mutation to the MADMGT cassette and useMADMTG/TG fe-
males andMADMGT/GT,gene-X; Cre+/+ males (Laukoter et al., 2020a). Here, red cells harboring
a homozygous mutation in gene-Xwill show patUPD (PP), while green wild-type cells will show
matUPD (MM) (Figure 3B). For efficient conduction of this control experiment, we recommend
to perform the color swap in the context of population analysis using a constitutively active
Cre driver and not a TM-inducible CreER.
Note: In order to reverse the parents to control for a potential genomic imprinting bias
of the parental origin of the mutation (parent swap), use MADMTG/TG,gene-X females and
MADMGT/GT; Cre+/+ males (Laukoter et al., 2020a) to generate MADMGT/TG,gene-X; Cre+/-
mosaic animals. Here, green cells harboring a homozygous mutation in gene-X will
show matUPD (MM), while red wild-type cells will show patUPD (PP) (Figure 3C).
Given that the generation of stock lines for your experiments will yield MADMTG/TG,gene-X fe-
males and MADMGT/GT; Cre+/+ males in any case, use the opportunity of having these
mice available and perform the parent swap in parallel to your ‘default breeding’ setup.
For efficient conduction of this control experiment, we recommend to perform it in the
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c. Perform experiment at your desired postnatal time point, for example when generation of cell
types is completed and the cells have reached a fully developed, mature state (in our examples
shown in this protocol we chose time points between P1 and P21).
Generation of experimental MADMmice for postnatal histological analysis of genetic mosaic
tissue in peripheral organs
Timing: 3 weeks–12 months
Figure 3. Breeding schemes for default setup, color swap, and parent swap
(A) Schematic showing the default breeding scheme using males where gene-X is meiotically linked to the MADM TG
cassette, while females transmit the GT cassette and the Cre driver. Resulting offspring will contain red wild-type cells
with uniparental maternal chromosome disomy (matUPD, MM), while green mutant cells will harbor uniparental
paternal chromosome disomy (patUDP, PP).
(B) Schematic of the breeding scheme for a color swap experiment using females homozygous for the MADM TG
cassette, while males transmit the Cre driver plus gene-Xmeiotically linked to the GT cassette. Resulting offspring will
have green wild-type cells with matUPD (MM), while red mutant cells will harbor patUPD (PP).
(C) Schematic of the breeding scheme for a parent swap experiment using females where gene-X is meiotically linked
to the MADM TG cassette, while males transmit the GT cassette and the Cre driver. Resulting offspring will contain red
wild-type cells with patUPD (PP), while green mutant cells will harbor matUPD (MM).
Parts of the figure were reproduced and adapted with permission from (Beattie et al., 2017).
ll
OPEN ACCESS
STAR Protocols 2, 100939, December 17, 2021 13
Protocol
8. Cross MADMGT/GT; HprtCre/+ females with MADMTG/TG,gene-X males in order to generate
offspring with genetic mosaic tissues.
a. Check for the vaginal plug to monitor successful mating and to facilitate the experimental
planning.
b. Males and females of the resulting F1 generation can be used as experimental animals (geno-
type will be MADMGT/TG,gene-X; HprtCre/+).
CRITICAL: The Hprt-Cre transgene is located on the X chromosome, with one of the two X
chromosomes undergoing random inactivation in females. Thus, Cre activity and MADM
labelling are highly variable in MADMGT/TG,gene-X; HprtCre/+ females. We therefore recom-
mend to primarily use males for your analysis in order to obtain reproducible results.
Note: Upon crossing MADMGT/GT; HprtCre/+ females with MADMTG/TG,gene-X males to
generate MADMGT/TG,gene-X; HprtCre/+ mosaic animals, green cells harboring a homozygous
mutation in gene-X will show patUPD, while red wild-type cells will show matUPD.
Note: If desired, perform color swap and parent swap (Laukoter et al., 2020a) as described in
the notes for step 7 of the protocol.
c. Perform the experiment at the desired postnatal time point, to e.g., analyze cellular pheno-
types arising during development in mature tissue and/or trace disease phenotypes when a
disease phenotype is evident (up to several months of age).
Mouse perfusion and dissection for collection of MADM-labelled tissue for histological
analysis
Timing: 12–16 h
This section of the protocol documents the perfusion and dissection of postnatal mice for organ
removal and further downstream histological analysis.
CRITICAL: 4% PFA should be ice-cold and protected from light.




d. Peristaltic pump or perfusion syringes
e. Dissection tools
f. 6-well plates
CRITICAL: Make sure no air bubbles are trapped in the tubes of the peristaltic pump or
within the syringe containing the perfusion buffers. Bubbles may destroy the tissue during
the perfusion process. Run the tubes of the pump with PBS prior to starting the perfusion
procedure to make sure all air is removed.
10. Anesthetize the animal by intraperitoneal injection of anesthesia working solution at a volume of
0.16–0.24 mL/10 g mouse (equivalent to 400–600 mg/kg).
CRITICAL: Mice require deep anesthesia before any further procedure can be applied.
Test the efficiency of anesthesia by pinching a paw with forceps. Only when the mouse
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11. Place the anesthetized animal in supine position on a perfusion tray and disinfect fur with 70%
ethanol.
12. Below the rib cage, make a medial incision with scissors and surgical forceps through the skin
and the underlying muscle layer (Figure 4A). Continue to cut laterally.
13. Lift the tip of the sternum and snip the diaphragm. Then trim the rib cage to expose the heart.
14. Using small iris scissors make an incision to the posterior end of the right atrium for the blood to
drain during the following perfusion procedure (Figure 4B).
15. Insert a needle attached to a peristaltic pump or a syringe filled with 13 PBS into the lower left
ventricle (Figure 4C).
16. Perfuse with PBS until the liver turns pale (requires approximately 5–10 mL of PBS).
17. Once complete, switch the perfusion solution to 4% PFA.
Note: Perfusion requirements need to be adjusted according to the age of the animals. (a) For
the perfusion of pups: perfuse manually using 10 mL syringes. Prepare 2 distinct 10 mL sy-
ringes: one filled with 13 PBS and another filled with 4% PFA. Once perfusion with PBS is
completed, replace PBS-containing syringe plus needle with fresh needle and syringe con-
taining PFA through the same puncture hole in the heart. (b) For the perfusion of juvenile
and adult mice, use a peristaltic pump. Place one end of the tube of the peristaltic pump
into a flask or Falcon tube filled with PBS. After perfusion with PBS (speed: 5 mL at 2–4 mL/
min in juvenile animals; 10 mL at 4–6 mL/min for adult mice), switch to 4% PFA.
CRITICAL: briefly stop the peristaltic pump and exchange the PBS solution with ice-cold
4% PFA. This is critical to avoid bubbles in the pump tubing. Resume perfusion with PFA
at the same speed.
18. Removemouse from perfusion pad and dissect the organ of interest. If organ of interest is brain,
continue to follow the protocol. If organ of interest is a peripheral organ, proceed to step 27.
19. Dissection of brain:
a. Decapitate mouse.
b. Remove the skin over the skull (Figure 4D).
c. Cut the skull at the naso-frontal suture (in front of the olfactory bulbs) (Figure 4E).
d. Then cut along the midline (Figure 4F), followed by a cut along the parietal-interparietal su-
tures.
e. Lift the skull to the side to expose the brain (Figure 4G).
f. Place curved forceps or a thin spatula underneath the brain and remove it from the skull (Fig-
ure 4H).
CRITICAL: Avoid mechanical damage of brain tissue during the dissection to ensure you
obtain intact tissue for high quality analysis.
20. Transfer the brain to a well filled with ice-cold 4%PFA in a 6-well plate (Figure 4I).
21. Incubate at 4C for minimum 10 h.
22. Next day, wash 33 with 13 PBS for 5 min each.
23. Transfer brain to a 15 mL Falcon tube filled with 10 mL of 30% Sucrose.
24. Incubate at 4C until the brain has sunk to the bottom of the Falcon tube.
25. Remove brain from sucrose and gently remove residual sugar from the surface of the brain using
lint-free tissues.
26. Depending on the cell type of interest and the needs of the experiment, embed brain in coronal
or sagittal orientation:
a. For coronal orientation (Figure 4J), place brain ventral-side down on a piece of lint-free tissue
and remove the cerebellum using a razor blade (Figures 4K and 4L). Place brain with the
caudal side down in an embedding mold (Figure 4M), fill mold and cover tissue with
O.C.T. Tissue tek and freeze. Once frozen, store it at 80C.
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Figure 4. Tissue harvesting for histological analysis of experimental MADM mice
(A–C) Mouse dissection and initiation of perfusion.
(D–Q) Mouse dissection to isolate and embed brain.
(R–V) Isolation and embedding of colon.
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b. For sagittal orientation (Figure 4N), place brain ventral-side down on a piece of lint-free tis-
sue and cut it in two halves along the midline using a razor blade (Figures 4O and 4P). Place
brain with the medial side down in an embeddingmold (Figure 4Q), fill mold and cover tissue
with O.C.T. Tissue tek and freeze. Once frozen, store it at 80C.
Pause point: You can keep the frozen tissue at 80C until further usage.
27. Dissection of peripheral organ (this protocol is using the colon as an example):
a. Remove colon from the mouse and place it on lint-free tissue.
b. Cut open longitudinally (Figure 4R).
c. Remove faeces.
d. Make colon into a Swiss roll by using a pipet tip to roll it up (Figure 4S).
e. Transfer colon into a histosette (Figure 4T) for further handling.
28. Incubate in a beaker filled with 4% PFA for 4 h at 22C–25C (Figure 4U).
29. Wash 33 with 13 PBS for 5 min each.
30. Incubate in 30% Sucrose at 4C for minimum 10 h.
31. Remove histosette with colon from sucrose, take out colon and gently remove residual sugar
from the surface of the organ by using lint-free tissues.
32. Transfer colon to an embedding mold, fill mold and cover tissue with O.C.T. Tissue Tek and
freeze (Figure 4V). Once frozen, store it at 80C.
Pause point: You can keep the frozen tissue at 80C until further usage.
CRITICAL: Optimal tissue freezing during embedding is achieved when embedding molds
are placed on dry ice. Control the tissue during the freezing process from time to time and
avoid loss of position within the mold.
Tissue sectioning for histological analysis
Timing: 30 min–3 h
This section of the protocol lists details on sectioning MADM-labelled tissue for confocal
microscopy.
33. Remove tissue from 80C and transfer to a cryostat cooled to 20C.
34. Let tissue adapt to temperature change for 20 min.
35. Remove tissue block from the embedding mold.
36. Attach the tissue block to the specimen disk in the cryostat by applying a drop of OCT to the disk
and placing the tissue block directly into the OCT. Allow to freeze for 1–2 min.
37. Insert disk with attached tissue block in the sectioning holder by placing the tissue in a correct
orientation.
Note: For brain sections, insert sectioning disc with cortex facing towards the top. For periph-
eral organ sections, insert sectioning disc with organ of choice in an orientation that guaran-
tees good sectioning quality for your required analysis.
38. Start cutting by trimming the tissue block in 45 mm thick sections until the region of interest is
reached.
39. Slice the tissue in 30 mm thick sections. Either collect the slices in individual wells of a 24 well
plate (= floating sections) or mount them directly onto frosted glass slides.
Pause point: Floating sections can be kept in PBS at 4C for up to 48 h. When longer storage
is required, exchange the PBS with cryoprotectant and store at 20C.
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Pause point: Directly mounted sections can be stored in a slide box at 20C until further
usage.
Tissue mounting
Timing: 15 min–1 h
This part of the protocol can be skipped if the sliced tissue is directly mounted onto frosted glass
slides in the course of the sectioning process. In that case, immediately proceed to step 45 of the
protocol. If you prepared floating sections, continue with step 40.
40. Fill a Petri dish with PBS-T.
41. Place a frosted glass slide at the edge of the petri dish so that is covered up nearly to the label
with PBS-T.
42. Transfer all of your desired sections into the dish filled with PBS-T.
43. Use a small paint brush to maneuver the sections onto the slide and arrange them side by side.
44. Once all sections are placed onto the slide (for brain usually1216 sections/slide), horizontally
transfer the slide to a dark slide chamber and let the sections dry completely (15 min) to make
them adhere to the glass. Either proceed to the next steps of the staining procedure or pause
the protocol at this point.




This section of the protocol explains the staining procedure for MADM-labelled cells together with
an additional, cell-type specific marker staining. All steps are performed at 22C–25C unless other-
wise stated. Please refer to troubleshooting problem 2 when observing variable signals.
45. If your sections were floating sections and have been freshly mounted and dried, immediately
proceed to step 46 of the protocol. If your sections were already mounted during sectioning
and stored at 20C, take the slides from the freezer and let them dry for 15 min.
46. Encircle staining area with a hydrophobic pen.
47. Rehydrate and wash sections 33 5 min with 13 PBS to remove residual PBS-T.
48. Meanwhile, heat up an oven to 85C. Take the opportunity to put the antigen retrieval buffer
into the oven to have the solution pre-heated. Our most commonly used antigen retrieval solu-
tion is Citrate Buffer pH 6.0.
49. Incubate your sections with 1mL pre-heated citrate buffer pH 6.0 for 25min at 85C in a dark and
closed staining chamber (make sure it is closed. If it is open, buffer will evaporate and samples
will dry out).
50. Remove the staining chamber and let chill on your bench for 15 min. Open it on one corner a tiny
bit so the samples can cool downmore efficiently (don’t open toomuch, otherwise the buffer will
evaporate and samples will dry out).
51. Wash 33 5 min with 13 PBS.
52. Incubate with 500 mL Blocking Solution for 1 h.
53. Place humidified tissues into the staining chamber to prevent your samples from dehydration
during the next steps of the protocol.
54. Dilute primary antibodies in Staining Solution, add 250 mL antibody mix for one sample and
incubate 8–12 h at 4C.
55. Wash 33 5 min with 13 PBS.
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56. Dilute secondary antibodies in Staining Solution, add 250 mL antibody mix for one sample and
incubate for 2 h.
57. Wash 33 5 min with 13 PBS.
58. Add 1 mL DAPI working solution for 15 min.
59. Wash 13 10 min in PBS
60. Embed the slides with Mowiol and let dry at 22C–25C for 30 min.
Pause point: Keep the slides at 4C until imaging. Image quality is highest upon timely
acquisition of images following the staining procedure. We recommend to image the sections
within 14 days after completion of step 60.
Note: Instead of mounting the floating sections onto glass slides prior to the staining proced-
ure, the whole staining protocol can be performed on floating sections in a 24well plate.
Buffers are removed manually using a pasteur pipet or a P1000. We recommend the following
volumes when performing stainings in 24well plates:
Here, sections should be mounted after the final washing step following the secondary antibody
staining. Mounting process is equivalent to steps 40 to 44 of the protocol. Once mounting and sec-
tion drying is completed, you can proceed with DAPI staining and Mowiol embedding (steps 58 to
60 of the protocol).
Microscopy and image processing
Timing: 1–12 h
In this section of the protocol, we describe the microscopy settings and subsequently required
confocal image processing for further downstream analysis.
61. For the analysis of MADM-labeled tissue we recommend to use an inverted confocal
microscope, in our case Zeiss LSM800 with corresponding image acquisition software ZEN
blue.
Buffer volumes per well for staining of floating cryosections
Reagent Volume (ml)
PBS 1,000
Antigen retrieval buffer 500
Blocking Buffer 500
Staining Buffer (including antibody mix) 250
DAPI working solution 500




Anti-chicken FITC Donkey 1:500
Anti-goat Alexa568 Donkey 1:1000




Anti-rabbit Alexa647 Donkey 1:1000
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62. Select the correct laser lines and filters. For MADM tissue with additional marker staining, select
excitation: 405 nm (for DAPI), 488 nm (for FITC / GFP), 561 nm (for Alexa568 / tdT) and 640 nm
(for Alexa647).
63. Set to pinhole to 1 airy unit for optimal imaging quality.
64. Select the functions ‘‘Z-stack’’ and ‘‘Tiles’’ from the acquisition dashboard.
65. Select objective, scanning speed, resolution and averaging appropriate to the needs of your ex-
periments.
66. Adjust laser intensity and gain for each channel.
67. Identify your area of interest and set position and imaging tiles to cover the area of interest.
Adjust the z-stack so that all MADM-labeled cells in the tissue are captured.
68. Assign the center position of your Z-stack to the tiles and the positions and click ‘‘Start’’ to
initiate image acquisition.
69. Save the image in .czi file format.
Note: For tissue overview images and cell number quantification, select a 103 objective
and use a scanning speed pixel dwell value of 1.52–2.06 ms (values 7–8 in the ZEN
blue image acquisition software) with resolution 1024 3 1024 and no averaging. For
high-quality images and morphological analysis, use a high magnification objective (e.g.
633) and use a scanning speed pixel dwell value of maximum 2.06 ms (up to value 7 in
the ZEN blue image acquisition software) with resolution 1024 3 1024 and 23 or 43
averaging.
Pause point: The protocol can be stopped at this point. Image processing and analysis can
be performed at any time after image acquisition.
70. Once image acquisition is completed, use the image processing dashboard in ZEN blue and
perform maximum intensity projection using the ‘‘Orthogonal Projection’’ function.
71. Following projection, perform ‘‘Stitching’’ function by fusing tiles.
72. Save the projected and stitched image as a new .czi file.
73. Export the projected and stitched .czi file to TIFF format. Export DAPI / GFP / tdT / Alexa647
channels individually for subsequent image analysis.
EXPECTED OUTCOMES
Compare your readout of green and red cells (such as cell number, cell position, morphological param-
eters, presence of tumors) in genetic mosaic MADM animals. Since the genotypes of red cells (wild-
type) and green cells (mutant) are different, any deviation from a comparable green-to-red (G/R)
read-out indicates a cell-autonomous function of gene-X in your cell type of interest.
In order to study stem cell output by counting cell numbers, determine the G/R cell ratio of your cell
type of interest (Figures 5F and 5H): If G/R ratio were above 1, it indicates a proliferation increase of
green mutant stem cells, whereas a G/R ratio below 1 indicates cell loss either through diminished
stem cell proliferation or apoptosis of either stem cells or their descendants. Thus, gene-X has a cell-
autonomous function in governing overall stem cell output.
To study cell migration, measure cell position and the number of red wild-type and green
mutant cells in certain positions (Figures 5L and 5N): A deviation of numbers of green cells vs. red
cells in particular bins is indicative of a cell migration alteration. A large absence of green
mutant neurons from cortical layers and their accumulation in the white-matter demonstrates
a cell-autonomous function of gene-X in neuronal migration. Based on the sparse endogenous
labeling with GFP and tdT, MADM is also well suited to study cell migration in live imaging
assays and 4D tracing with high resolution (Riccio et al., 2016; Hippenmeyer et al., 2010).
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Figure 5. Examples and analysis of genetic mosaic MADM animals with mosaicism in the brain
(A–C) Schematic of G2-X MADM events resulting in (A) genetic mosaic tissue using (B) constitutively active Cre driver for population analysis and (C)
tamoxifen-inducible CreER driver for clonal analysis.
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Determine morphological parameters, such as the height index (Figure 5R): calculate the height in-
dex by the formula a/b (a = the distance from the pial surface to the top of the arbor of a Purkinje cell;
b= the molecular layer span) and compare the values for red wild-type and green mutant cells side-
by-side. If green mutant cells display higher values for height parameters than red wild-type cells,
this result indicates a decreased height of the analyzed cells. As a conclusion, gene-X exerts a
cell-autonomous function in cellular morphology.
In order to study a disease model such as tumorigenesis (Figure 6C), compare the numbers and area
of red and green tumors in your tissue of choice. An increased number of green tumors and tumor
area indicates a cell-autonomous function of gene-X in stem cell proliferation and tumor initiation,
whereas a decreased number indicates a cell-autonomous disadvantage in tumor growth.
QUANTIFICATION AND STATISTICAL ANALYSIS
Timing: several hours or days
Figure 5. Continued
(D–H) Analysis of central nervous system (CNS) stem cell output in Lgl1-MADM mice using Lgl1 mutant allele (Klezovitch et al., 2004). (D) schematic of
Lgl1-MADM cortical tissue; (E and F) population analysis of Lgl1 using Emx1-Cre driver (Gorski et al., 2002) with (E) overview of a representative brain
section at P21, (E0) insert showing the cortex, and (F) quantification of the G/R ratio of astrocytes from wild-type mice and Lgl1-MADM mice; (G and H)
clonal analysis of Lgl1 using Emx1-CreER driver (Kessaris et al., 2006) with (G) reconstruction of a representative clone at P21 and (H) quantification of the
number of green astrocytes in green subclones for wild-type and Lgl1 mutant clones. Scale bars: (E) 500 mm, (E0) 60 mm, (G) 70 mm). Values represent
mean G SEM. ns, nonsignificant, ***p < 0.001. Parts of the figure and its legend were adapted and reused from (Beattie et al., 2017) with permission.
(I–N) Analysis of cortical projection neuron migration in Ndel1-MADM mice using Ndel1 knock-out allele (Sasaki et al., 2005). (I) schematic of Ndel1-
MADM cortical tissue; (J–L) population analysis of Ndel1 using Emx1-Cre driver (Gorski et al., 2002) with (J) overview of a representative image of the
cortex section at P1, (K) schematic indicating partitioning of the cortex into layers and layer-specific quantification of red and green neurons, and (L)
quantification of the relative distribution of red wild-type and green Ndel1mutant cells in the respective layers; (M and N) clonal analysis of Ndel1 using
Nestin-CreER driver [line 1 in (Imayoshi et al., 2006)] with (M) reconstruction of a representative clone at E18.5 and (N) quantification of the relative
distribution of red wild-type and greenNdel1mutant cells in the respective layers. Scale bars: (J) 150 mm, (M) 100 mm. Values represent mean G SEM. ns,
nonsignificant; *p < 0.05 and ***p < 0.001. Parts of the figure and its legend were adapted and reused from (Hippenmeyer et al., 2010) with permission.
(O–R) Analysis of Purkinje cell morphology in TrkC-MADMmice using TrkC knock-out allele (Tessarollo et al., 1997) andNestin-Cre driver (Petersen et al., 2002). (O)
schematic of TrkC-MADM neuronal tissue; (P and Q) representative high magnification images of (P) red wild-type and (Q) green TrkC mutant Purkinje cells in the
cerebellum of P21 TrkC-MADMmice, (R) quantification of the height deficiency index of red wild-type and green TrkCmutant cells within the Molecular layer of the
cerebellum. Scale bars: (P andQ) 50 mm. Presentedmorphology values aremeansG SEM. *** p < 0.001, one-way analysis of variance (ANOVA) with Tukey’s multiple
comparisons test. Parts of the figure and its legend were adapted and reused from (Joo et al., 2014) with permission.
Figure 6. Example and analysis of genetic mosaic MADM mice with mosaicism in peripheral organs
(A–C) MADM analysis of Apc tumor suppressor gene in the colon using Apc-flox allele (Cheung et al., 2010) and Hprt-Cre driver (Tang et al., 2002). (A)
schematic of Apc-MADM tissue; (B) representative image of an adenoma arising from green Apc mutant stem cells in the colon of a 3month old Apc-
MADM mouse. Inserts (i) and (ii) show unlabeled healthy colon epithelium, where proliferating cells (as indicated by M-Phase marker staining with P-H3
antibody) are only located in the crypt bottom, but not above the crypt region or along the differentiated epithelium. In contrast insert (iii) highlights a
subepithelial region within the adenoma displaying proliferating cells. (C) Quantification of the tumor area originating from red wild-type and green
Apc mutant cells. Scale bars: (B) 200 mm, (i, ii, iii) 40 mm. Values represent means G standard deviation.
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Once a stem cell undergoes a G2-X MADM event, one green labelled mutant and one red labelled
wild-type daughter cell is generated in an unlabeled environment (Figure 5A). Such sparsely labelled
cells can be subjected to a variety of downstream analyses, such as lineage tracing, cell number
quantification, positional analysis or morphological analysis (Figure 5).
These distinct types of downstream analysis can be performed for both, population and clonal anal-
ysis. While population analysis results in sparse MADM-labeling with no spatiotemporal information
(Figure 5B) clonal analysis employing a TM-inducible CreER driver can provide high spatiotemporal
resolution (Figure 5C).
The following steps of the protocol provide a short description of the distinct types of
histological analysis enabled by the MADM-induced genetic mosaics (also see troubleshooting
problem 3):
1. For the determination of stem cell output, quantify the number of red and green cells in your ac-
quired images using the counting tool in Photoshop. To do this, load all individual channel im-
ages into one image stack to keep channels separate. Use the counting tool to manually quantify
the number of distinct cell types derived from red wild-type and green mutant stem cells. After-
wards, calculate and plot the green-to-red (G/R) cell ratio. (Figures 5D–5H).
Alternatives: if photoshop is not accessible, alternative freely accessible software such as Fiji
can be used for the quantification of green and red cells. In Fiji, use the tool ‘multi-points’ for
quantification.
2. For the assessment of cellular migration, partition the tissue into defined layers or bins. Next,
quantify the number of individual red wild-type and green mutant cells within these layers or
bins by using the ‘counting’ tool in photoshop. Plot the cell number per bin for red and green cells
side-by-side and compare their distribution to determine if mutant cells are found in a different
position than wild-type cells (Figures 5I–5N).
3. In order to determine cellular morphology, import your .czi image into a software appropriate for
morphological analysis, such as Imaris and use the filament tracer function. Determine parameters
such as cell volumeor complexity using Sholl analysis. Compare the values for redwild-type andgreen
mutant cells to assess if the mutation causes a morphology phenotype (Figures 5O–5R). For assess-
ment of cell height, define specific parameters, such as the distance from the pial surface to the
top of the arbor of a Purkinje cell (parameter a) and themolecular layer span (parameter b) (Figure 5Q).
Suchparameters can bemeasuredwith the ‘ruler’ tool using ZEN software on the .czi file of your image
or in photoshop or Fiji using other image formats such as .tif.
4. For disease modeling such as the investigation of tumor initiation and growth, quantify the num-
ber of individual tumors using the counting tool in photoshop or determine the size of the tumor
area by delineation of the tumor margin in ZEN blue or in photoshop (Figure 6).
LIMITATIONS
The genome-wide library of MADM mice allows to employ MADM to study the vast majority, nearly
genome-wide (>96%), of autosomal genes in the mouse genome. Mouse autosomes have a telocen-
tric conformation and we thus inserted the MADM cassettes as close as possible to the centromere
to maximize the number of genes located distally to the MADM cassette insertion site. In order to be
meiotically linked to the corresponding MADM chromosome, the gene of interest needs to be
located distally to the MADM cassette. The MADM principle relies on meiotic recombination to
genetically link a mutation to the MADM cassette. However, too close proximity of the gene of in-
terest to the MADM cassette might make a recombination event difficult or impossible. In such
cases, other techniques offering sparse induction of a mutation of choice could be used, such as
MADR (Kim et al., 2019), Dual ifgMosaic (Pontes-Quero et al., 2017) or BATTLE (Kohara et al., 2020).
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The library of MADM mice currently does not include strains with MADM cassettes inserted on the
sex chromosomes, thus while the vast majority (>96%) of genes can be studied, the genes located on
the X or Y chromosome are not yet covered by the MADM technique.
TROUBLESHOOTING
Problem 1
Low number of experimental mice (breeding of experimental MADM mice – steps 1–6).
Potential solution 1
Make sure the genetic background of yourmice does not exhibit negative effects on their mating perfor-
mance. Increase the number of breeding cages to gain a good number of F1 or F2 mice to start with.
Furthermore, control whether you have correctly followed the provided breeding strategies.
Wrongly genotyped or selected parental mice can result in strongly decreased efficiency in the gen-
eration of experimental animals.
Problem 2
Weak or variable MADM signal without staining for GFP and tdT (Staining – steps 45–60).
Potential solution 2
Endogenous fluorescence intensity of GFP and tdT are pH sensitive. Make sure all of your buffers
have the correct pH.
Additionally, perform staining for GFP and tdT using the antibodies indicated above.
Problem 3
Highly variable results in MADM lines with low recombination frequency (Quantification and Data
Visualization – steps 74–77).
Potential solution 3
Analysis of all 19 MADM lines showed that different MADM chromosomes harbor distinct recombi-
nation frequencies [sparse, intermediate or dense, (Contreras et al., 2021)]. The required number of
experimental animals and the number of tissue sections used for analysis need to be scaled up when
working with a MADM chromosome that gives sparse labeling. We recommend using the entire
amount of tissue sections available for one animal to avoid introduction of an analysis bias when
only using a few sections from a low recombination line.
Problem 4
Low breeding performance (Generation of experimental MADMmice for histological analysis, steps
7–8).
Potential solution 4
Discuss with your veterinarian how to optimize themating conditions (e.g., by providing special food
or housing conditions).
Problem 5
High abortion rate upon Tamoxifen injection for clonal analysis (Generation of experimental MADM
mice for histological analysis, step 7).
Potential solution 5
Titrate the concentration of Tamoxifen according to your experimental needs to find an optimal bal-
ance between survival and clone numbers. Additionally, recover pups by caesarian sections and
perform fostering to increase the survival rate of experimental animals.
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Further information and requests for resources and reagents should be directed to and will be ful-
filled by the lead contact Simon Hippenmeyer (simon.hippenmeyer@ist.ac.at).
Materials availability
This study did not generate new unique reagents.
Data and code availability
No custom code is necessary to perform this protocol.
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